Deutsche Labs Inc.
Indian Pharmaceutical Exporter ยท Advanced Antibiotics Specialist ยท $436.9K Total Trade ยท DGFT Verified
Deutsche Labs Inc. is an Indian pharmaceutical exporter with a total trade value of $436.9K across 3 products in 3 therapeutic categories. Based on 15 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Rifampicin ($240.9K), Pyrazinamide ($150.0K), Mefloquine ($46.0K).
Deutsche Labs Inc. โ Export Portfolio & Destination Treemap

Who is Deutsche Labs Inc.? โ Company Overview & Market Position
Deutsche Labs Inc. is an Indian pharmaceutical exporter specializing in finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. The company is headquartered at 304 Sammani 11, Opposite Shell Petrol Pump, Satellite, Ahmedabad, Gujarat, India. The Corporate Identification Number (CIN) for Deutsche Labs Inc. is 26IN0805006362. (en.nbd.ltd) While specific revenue figures are not publicly disclosed, the company has demonstrated a consistent export performance, with a total export value of $437,000 USD across 15 shipments from 2022 to 2026. The workforce comprises approximately 20 employees, reflecting a focused operational structure. The company's official website is not publicly available.